CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 106 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $735,000 | +17.0% | 5,903 | 0.0% | 0.24% | +6.7% |
Q2 2016 | $628,000 | -14.4% | 5,903 | -8.0% | 0.22% | -26.1% |
Q1 2016 | $734,000 | -25.8% | 6,413 | -7.6% | 0.30% | -24.1% |
Q4 2015 | $989,000 | +26.3% | 6,942 | +1.6% | 0.40% | +30.8% |
Q3 2015 | $783,000 | – | 6,832 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |